TWO · Financial Statements

General Biologicals Corporation (4117.TWO) Financial Statements

$8.45 TWO: 4117.TWO Market Cap $598.19M

Full income statement, balance sheet, and cash flow statement for General Biologicals Corporation (4117.TWO), plus valuation and return ratios.

Annual financials are not yet available for this stock.

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-44.43
FCF Yield—
Quick Ratio1.39
Interest Coverage—
Return 1Y-43.67%
Return 3Y-63.18%
Return 5Y-70.96%

General Biologicals Corporation (4117.TWO) financials — frequently asked questions

What is 4117.TWO EV/EBITDA?

General Biologicals Corporation's enterprise value to EBITDA (EV/EBITDA) ratio is -44.43. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
4117.TWO Overview 4117.TWO Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.